<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Acute Cellulitis – One‑Page Clinical Algorithm (NICE CKS 2025)</title>
  <style>
    :root {
      --bg: #0b1020;
      --panel: #12182b;
      --muted: #8ea0c7;
      --text: #e8eeff;
      --accent: #7aa2ff; /* primary */
      --accent-2: #4ce0b3; /* success */
      --warn: #ffd166; /* warning */
      --danger: #ff6b6b; /* danger */
      --ring: rgba(122, 162, 255, .45);
      --shadow: 0 10px 30px rgba(0,0,0,.35), 0 1px 0 rgba(255,255,255,.03) inset;
      --radius: 18px;
      --radius-sm: 12px;
      --maxw: 1080px;
      --mono: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", "Courier New", monospace;
      --sans: Inter, ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
    }
    @media (prefers-color-scheme: light){
      :root { --bg:#f6f8ff; --panel:#ffffff; --text:#0b1020; --muted:#5c6b8a; --shadow: 0 12px 28px rgba(22,34,78,.08), 0 1px 0 rgba(10,12,27,.04) inset; }
    }

    * { box-sizing: border-box; }
    html, body { height: 100%; }
    body {
      margin: 0; font-family: var(--sans);
      color: var(--text); background: radial-gradient(1200px 800px at 80% -10%, rgba(122,162,255,.12), transparent 60%),
      radial-gradient(900px 600px at -10% 110%, rgba(76,224,179,.12), transparent 50%), var(--bg);
      line-height: 1.35;
    }
    .container { max-width: var(--maxw); margin: 0 auto; padding: 28px 20px 60px; }

    /* Header */
    .appbar { position: sticky; top: 0; z-index: 20; backdrop-filter: blur(10px); background: color-mix(in oklab, var(--bg), transparent 20%);
      border-bottom: 1px solid color-mix(in oklab, var(--text), transparent 90%);
    }
    .appbar-inner { display: grid; grid-template-columns: 1fr auto; align-items: center; gap: 16px; max-width: var(--maxw); margin: 0 auto; padding: 14px 20px; }
    .brand { display:flex; align-items:center; gap:12px; }
    .logo { width: 36px; height: 36px; border-radius: 10px; background: linear-gradient(145deg, var(--accent), #9fd0ff); box-shadow: var(--shadow); display:grid; place-items:center; }
    .logo svg { width: 22px; height: 22px; color: #0b1020; }
    h1 { font-size: clamp(18px, 3vw, 22px); margin: 0; letter-spacing:.2px; font-weight: 700; }
    .subtle { color: var(--muted); font-weight: 500; }

    .actions { display: flex; align-items: center; gap: 10px; }
    .search { position: relative; }
    .search input{ width: min(46vw, 360px); background: var(--panel); color: var(--text); border: 1px solid color-mix(in oklab, var(--text), transparent 88%);
      border-radius: 32px; padding: 10px 36px 10px 40px; outline: none; box-shadow: var(--shadow); transition: border-color .2s, box-shadow .2s; }
    .search input:focus{ border-color: var(--accent); box-shadow: 0 0 0 6px var(--ring), var(--shadow); }
    .search svg { position: absolute; left: 12px; top: 50%; transform: translateY(-50%); width: 18px; height: 18px; color: var(--muted); }

    .btn { appearance: none; border: 1px solid color-mix(in oklab, var(--text), transparent 80%); border-radius: 999px; padding: 10px 14px; background: var(--panel); color: var(--text);
      font-weight: 600; letter-spacing:.2px; display:inline-flex; align-items:center; gap:8px; box-shadow: var(--shadow); cursor:pointer; }
    .btn:hover{ transform: translateY(-1px); }

    /* Intro Card */
    .intro { margin-top: 24px; background: linear-gradient(180deg, color-mix(in oklab, var(--panel), transparent 0%), color-mix(in oklab, var(--panel), transparent 0%)); border-radius: var(--radius); padding: 18px; border: 1px solid color-mix(in oklab, var(--text), transparent 92%); box-shadow: var(--shadow); }
    .meta { display:flex; flex-wrap:wrap; gap:8px; margin-top: 6px; }
    .chip { font: 600 12px/1 var(--sans); letter-spacing:.3px; padding:8px 10px; border-radius: 999px; border: 1px solid color-mix(in oklab, var(--text), transparent 86%); color: var(--muted); background: color-mix(in oklab, var(--panel), transparent 0%); }
    .chip strong { color: var(--text); }

    /* Grid sections */
    .grid { display: grid; grid-template-columns: repeat(12, 1fr); gap: 16px; margin-top: 18px; }
    .card { grid-column: span 12; background: var(--panel); border-radius: var(--radius); padding: 18px; border: 1px solid color-mix(in oklab, var(--text), transparent 90%); box-shadow: var(--shadow); }
    .card h2 { margin: 0 0 12px; font-size: clamp(18px, 2.4vw, 20px); letter-spacing:.2px; }
    .card .lead { color: var(--muted); margin: 6px 0 0; }
    .pill { display:inline-block; padding: 6px 10px; border-radius: 999px; font: 700 12px var(--sans); letter-spacing:.3px; }
    .pill.warn { background: color-mix(in oklab, var(--warn), transparent 80%); color: var(--warn); border: 1px solid color-mix(in oklab, var(--warn), transparent 60%); }
    .pill.danger { background: color-mix(in oklab, var(--danger), transparent 85%); color: var(--danger); border: 1px solid color-mix(in oklab, var(--danger), transparent 60%); }
    .pill.ok { background: color-mix(in oklab, var(--accent-2), transparent 80%); color: var(--accent-2); border: 1px solid color-mix(in oklab, var(--accent-2), transparent 60%); }

    ul.list { margin: 10px 0 0 0; padding: 0 0 0 20px; }
    ul.list li { margin: 8px 0; }

    /* Two-column and three-column responsives */
    .span-6 { grid-column: span 12; }
    .span-4 { grid-column: span 12; }
    @media (min-width: 860px){
      .span-6 { grid-column: span 6; }
      .span-4 { grid-column: span 4; }
    }

    /* Dose table */
    table { width: 100%; border-collapse: collapse; margin-top: 10px; font-size: 14px; }
    th, td { padding: 10px 12px; border-bottom: 1px dashed color-mix(in oklab, var(--text), transparent 86%); text-align: left; vertical-align: top; }
    th { color: var(--muted); font-weight: 700; text-transform: uppercase; font-size: 12px; letter-spacing:.4px; }
    tbody tr:hover { background: color-mix(in oklab, var(--panel), transparent 0%); }
    code { font-family: var(--mono); font-size: 12px; color: var(--muted); }

    /* Collapsible */
    details { border-radius: var(--radius-sm); border: 1px solid color-mix(in oklab, var(--text), transparent 90%); background: color-mix(in oklab, var(--panel), transparent 0%); padding: 10px 12px; }
    summary { cursor: pointer; font-weight: 700; }

    /* Footer */
    footer { margin-top: 26px; color: var(--muted); font-size: 13px; display:flex; justify-content: space-between; align-items: center; gap: 12px; }

    /* Print styles */
    @media print {
      :root { --bg: #fff; --panel:#fff; --text:#000; --muted:#333; }
      body { background: #fff; }
      .appbar, .actions, .search, .btn.print-hide { display: none !important; }
      .card, .intro { box-shadow: none; border: 1px solid #0002; }
      .container { padding: 0; }
      a { color: #000; text-decoration: none; }
    }
  </style>
</head>
<body>
  <header class="appbar">
    <div class="appbar-inner">
      <div class="brand">
        <div class="logo" aria-hidden="true">
          <!-- medical cross icon -->
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M12 5v14M5 12h14"/></svg>
        </div>
        <div>
          <h1>Acute Cellulitis – One‑Page Clinical Algorithm</h1>
          <div class="subtle">NICE CKS (last revised June 2025) • Primary Care • Age ≥ 1 month</div>
        </div>
      </div>
      <div class="actions">
        <div class="search" role="search">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="11" cy="11" r="8"/><path d="m21 21-4.3-4.3"/></svg>
          <input id="q" type="search" placeholder="Quick filter (e.g. ‘doxycycline’, ‘Eron’)" aria-label="Filter content" />
        </div>
        <button class="btn" id="printBtn" title="Print (P)">
          <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M6 9V2h12v7"/><path d="M6 18H4a2 2 0 0 1-2-2v-5a2 2 0 0 1 2-2h16a2 2 0 0 1 2 2v5a2 2 0 0 1-2 2h-2"/><path d="M6 14h12v8H6z"/></svg>
          Print
        </button>
      </div>
    </div>
  </header>

  <main class="container" id="content">
    <section class="intro">
      <p class="subtle" style="margin:0">Built for quick, in‑consultation decisions. Use the search to filter sections in real time. Print‑friendly.</p>
      <div class="meta">
        <span class="chip">Scope: <strong>Acute cellulitis in primary care</strong> (excludes bites, diabetic foot, persistent/recurrent detailed mgmt)</span>
        <span class="chip">Adults & Children: <strong>≥ 1 month</strong></span>
        <span class="chip">Severity: <strong>Eron I–IV</strong> framework</span>
      </div>
    </section>

    <section class="grid" id="grid">
      <!-- Diagnosis -->
      <article class="card span-6" data-tags="diagnosis history exam eron severity mimics dvt gout eczema allergic insect bite features unilateral leg lower limb">
        <h2>1) Diagnosis</h2>
        <ul class="list">
          <li>Typical features: acute <strong>red, hot, swollen, tender</strong> skin; usually <strong>unilateral lower limb</strong>.</li>
          <li>Systemic features may include fever, malaise; check vitals.</li>
          <li>Exclude mimics: DVT, gout, septic arthritis, contact dermatitis/eczema, insect bite, venous insufficiency, erysipelas.</li>
          <li>Look for skin breaks (ulcer, wound, tinea pedis, eczema); assess oedema/lymphoedema.</li>
          <li><strong>Eron severity</strong>: I (no systemic toxicity), II (systemically unwell or significant comorbidity), III (marked systemic upset/unstable comorbidity or limb‑threatening), IV (sepsis or life‑threatening e.g., necrotizing fasciitis).</li>
          <li>Investigations not routine. Consider swab only if <em>broken skin</em> and: penetrating injury, water exposure, or infection acquired outside the UK. In systemic illness/comorbidity: FBC, CRP/ESR, U&amp;Es, LFTs.</li>
        </ul>
      </article>

      <!-- Admit / Refer -->
      <article class="card span-6" data-tags="admit referral red flags necrotizing fasciitis sepsis orbital osteomyelitis septic arthritis lymphangitis spreading failure oral unable immunocompromised facial periorbital recurrent prophylaxis">
        <h2>2) <span class="pill danger">Admit / Urgent Refer if</span></h2>
        <ul class="list">
          <li>Suspected <strong>necrotizing fasciitis</strong>, <strong>sepsis</strong>, <strong>orbital cellulitis</strong>, osteomyelitis, or septic arthritis.</li>
          <li>Severe systemic illness: confusion, tachycardia, tachypnoea, hypotension.</li>
          <li>Limb‑threatening infection / severe immunocompromise.</li>
          <li>Facial or periorbital cellulitis (unless very mild).</li>
          <li>Spreading infection not responding to oral antibiotics; or unable to take oral therapy.</li>
          <li>Recurrent cellulitis (≥2 episodes/12 months): consider secondary care advice for prophylaxis.</li>
        </ul>
      </article>

      <!-- Primary care mgmt -->
      <article class="card span-6" data-tags="management primary care mark pen edges analgesia paracetamol ibuprofen fluids elevation compression emollients risk factors diabetes eczema tinea pedis venous obesity">
        <h2>3) Primary Care Management</h2>
        <ul class="list">
          <li>Mark edges with a single‑use marker to monitor spread.</li>
          <li>Supportive: elevate limb, encourage fluids, analgesia (paracetamol/ibuprofen).</li>
          <li>Avoid compression garments in the acute phase.</li>
          <li>Skin care: regular <strong>emollients</strong> to prevent dryness/cracking.</li>
          <li>Address risk factors: diabetes control, treat eczema/tinea pedis, manage venous disease/oedema, weight management.</li>
        </ul>
      </article>

      <!-- Antibiotics Adults -->
      <article class="card span-6" data-tags="antibiotics adults flucloxacillin clarithromycin doxycycline erythromycin pregnancy penicillin allergy facial eye nose co-amoxiclav">
        <h2>4) Antibiotic Treatment — <span class="pill ok">Adults</span></h2>
        <table aria-label="Adult antibiotic choices">
          <thead><tr><th>Scenario</th><th>Choice &amp; Dose</th><th>Duration</th></tr></thead>
          <tbody>
            <tr>
              <td>First‑line</td>
              <td><strong>Flucloxacillin</strong> 500–1000 mg <strong>QDS</strong></td>
              <td>5–7 days</td>
            </tr>
            <tr>
              <td>Penicillin allergy / unsuitable</td>
              <td>
                <strong>Clarithromycin</strong> 500 mg <strong>BD</strong> <em>or</em>
                <strong>Doxycycline</strong> 200 mg day 1 → 100 mg <strong>OD</strong>
              </td>
              <td>5–7 days total</td>
            </tr>
            <tr>
              <td>Pregnancy (penicillin‑allergic)</td>
              <td><strong>Erythromycin</strong> 500 mg <strong>QDS</strong></td>
              <td>5–7 days</td>
            </tr>
            <tr>
              <td>Near eye/nose <em>(seek advice)</em></td>
              <td><strong>Co‑amoxiclav</strong> 500/125 mg <strong>TDS</strong></td>
              <td>7 days</td>
            </tr>
          </tbody>
        </table>
      </article>

      <!-- Adults with lymphoedema -->
      <article class="card span-6" data-tags="lymphoedema adults prolonged therapy flucloxacillin clarithromycin amoxicillin">
        <h2>4a) Adults with Lymphoedema</h2>
        <table aria-label="Adults with lymphoedema antibiotic choices">
          <thead><tr><th>Choice</th><th>Dose</th><th>Duration</th></tr></thead>
          <tbody>
            <tr><td><strong>Flucloxacillin</strong></td><td>500–1000 mg QDS</td><td><strong>14 days</strong></td></tr>
            <tr><td>Amoxicillin (if flucloxacillin not tolerated)</td><td>500 mg TDS</td><td>14 days</td></tr>
            <tr><td>Clarithromycin (penicillin allergy)</td><td>500 mg BD</td><td>14 days</td></tr>
          </tbody>
        </table>
        <p class="lead">Note: skin discoloration may persist for months post‑cellulitis and doesn’t mandate ongoing antibiotics.</p>
      </article>

      <!-- Paediatrics -->
      <article class="card span-6" data-tags="children paediatrics dosing flucloxacillin co-amoxiclav clarithromycin erythromycin pregnancy adolescent eye nose metronidazole anaerobes">
        <h2>4b) Antibiotic Treatment — <span class="pill ok">Children ≥ 1 month</span></h2>
        <details>
          <summary>Summary (tap to expand)</summary>
          <ul class="list">
            <li><strong>Flucloxacillin</strong> × 5–7 days (age/weight‑based).</li>
            <li>If unsuitable → <strong>co‑amoxiclav</strong> × 5–7 days.</li>
            <li>Penicillin allergy → <strong>clarithromycin</strong> × 5–7 days (adolescent pregnancy: <strong>erythromycin</strong>).</li>
            <li>Near eye/nose → <strong>co‑amoxiclav</strong> × 7 days (seek advice). If anaerobes suspected: <strong>clarithromycin + metronidazole</strong> × 7 days (age‑based dosing).</li>
          </ul>
        </details>
        <table aria-label="Selected paediatric dosing (concise)">
          <thead><tr><th>Drug</th><th>Age / Weight</th><th>Dose</th><th>Duration</th></tr></thead>
          <tbody>
            <tr><td>Flucloxacillin</td><td>1 mo–1 yr</td><td>62.5–125 mg QDS</td><td>5–7 d</td></tr>
            <tr><td>Flucloxacillin</td><td>2–9 yr</td><td>125–250 mg QDS</td><td>5–7 d</td></tr>
            <tr><td>Flucloxacillin</td><td>10–17 yr</td><td>250–500 mg QDS</td><td>5–7 d</td></tr>
            <tr><td>Co‑amoxiclav</td><td>1–11 mo</td><td>0.25 ml/kg of 125/31 susp <strong>TDS</strong> (double dose if severe)</td><td>5–7 d</td></tr>
            <tr><td>Co‑amoxiclav</td><td>1–5 yr</td><td>0.25 ml/kg or 5 ml of 125/31 susp <strong>TDS</strong> (double dose if severe)</td><td>5–7 d</td></tr>
            <tr><td>Co‑amoxiclav</td><td>6–11 yr</td><td>0.15 ml/kg or 5 ml of 250/62 susp <strong>TDS</strong> (double dose if severe)</td><td>5–7 d</td></tr>
            <tr><td>Co‑amoxiclav</td><td>12–17 yr</td><td>250/125 mg or 500/125 mg <strong>TDS</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>&lt;8 kg</td><td>7.5 mg/kg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>8–11 kg</td><td>62.5 mg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>12–19 kg</td><td>125 mg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>20–29 kg</td><td>187.5 mg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>30–40 kg</td><td>250 mg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Clarithromycin</td><td>12–17 yr</td><td>250–500 mg <strong>BD</strong></td><td>5–7 d</td></tr>
            <tr><td>Near eye/nose</td><td>Children</td><td><strong>Co‑amoxiclav</strong> <strong>TDS</strong> × 7 d (seek advice)</td><td></td></tr>
            <tr><td>Suspected anaerobes</td><td>1 mo</td><td><strong>Clarithromycin + Metronidazole</strong> 7.5 mg/kg <strong>BD</strong> / <strong>BD</strong></td><td>7 d</td></tr>
            <tr><td>Suspected anaerobes</td><td>2 mo–11 yr</td><td><strong>Clarithromycin + Metronidazole</strong> 7.5 mg/kg <strong>BD</strong> / 7.5 mg/kg <strong>TDS</strong> (max 400 mg)</td><td>7 d</td></tr>
            <tr><td>Suspected anaerobes</td><td>12–17 yr</td><td><strong>Clarithromycin + Metronidazole</strong> as adult; Metronidazole 400 mg <strong>TDS</strong></td><td>7 d</td></tr>
          </tbody>
        </table>
      </article>

      <!-- Follow-up -->
      <article class="card span-6" data-tags="follow up review 2-3 days safety net culture swab broken skin atypical exposure water penetrating abroad resistant narrow-spectrum">
        <h2>5) Follow‑Up (2–3 days)</h2>
        <ul class="list">
          <li>Reassess at <strong>48–72 hours</strong>.</li>
          <li>Consider alternative diagnoses if poor response.</li>
          <li>Swab if not already done and broken skin with atypical exposures (penetrating injury, water‑borne organisms, outside UK).</li>
          <li>De‑escalate or switch antibiotics per results if no improvement; use narrow‑spectrum where possible.</li>
          <li>Refer/seek specialist advice if spreading and not responding to oral therapy.</li>
        </ul>
      </article>

      <!-- Prevention -->
      <article class="card span-6" data-tags="prevention recurrence emollients foot care diabetes weight oedema venous lymphoedema prophylaxis">
        <h2>6) Prevention of Recurrence</h2>
        <ul class="list">
          <li>Manage skin integrity: emollients; treat tinea pedis; manage eczema and ulcers.</li>
          <li>Risk factor modification: weight management, glycaemic control, manage oedema/venous insufficiency, foot care (esp. diabetes).</li>
          <li>Recurrent episodes (≥2/12 mo): consider referral for prophylactic antibiotics guidance.</li>
        </ul>
      </article>
    </section>

    <footer>
      <div>✔ Designed for quick reference. Not a substitute for full SPC/BNF or local antimicrobial guidance.</div>
      <div class="subtle">Keyboard: <code>/</code> to focus search, <code>P</code> to print</div>
    </footer>
  </main>

  <script>
    // Quick filter
    const q = document.getElementById('q');
    const cards = Array.from(document.querySelectorAll('.card'));
    q.addEventListener('input', () => {
      const term = q.value.trim().toLowerCase();
      cards.forEach(c => {
        if (!term) { c.style.display = ''; return; }
        const hay = (c.textContent + ' ' + (c.dataset.tags || '')).toLowerCase();
        c.style.display = hay.includes(term) ? '' : 'none';
      });
    });

    // Keyboard shortcuts
    window.addEventListener('keydown', (e) => {
      if (e.key === '/' && document.activeElement !== q){ e.preventDefault(); q.focus(); }
      if ((e.key.toLowerCase() === 'p') && !e.metaKey && !e.ctrlKey) { e.preventDefault(); window.print(); }
    });

    // Print button
    document.getElementById('printBtn').addEventListener('click', () => window.print());
  </script>
</body>
</html>
